de Mendoza C - Search Results

1

Changing patterns in HIV reverse transcriptase resistance mutations after availability of tenofovir.

de Mendoza C, Jiménez-Nacher I, Garrido C, Barreiro P, Poveda E, Corral A, Zahonero N, González-Lahoz J, Soriano V. de Mendoza C, et al. Clin Infect Dis. 2008 Jun 1;46(11):1782-5. doi: 10.1086/588045. Clin Infect Dis. 2008. PMID: 18426370

2

Performance of an ultrasensitive assay to test undetectable viral load specimens using the branched DNA assay.

de Mendoza C, Holguin A, Soriano V. de Mendoza C, et al. AIDS. 1998 Sep 10;12(13):1727-9. AIDS. 1998. PMID: 9764800 No abstract available.

3

Higher antiviral activity of antiretroviral regimens including protease inhibitors.

de Mendoza C, Soriano V, Rodríguez-Rosado R, González-Lahoz J. de Mendoza C, et al. AIDS. 1999 May 28;13(8):998-9. doi: 10.1097/00002030-199905280-00021. AIDS. 1999. PMID: 10371186 No abstract available.

4

Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.

Holguín A, de Mendoza C, Soriano V. Holguín A, et al. Among authors: de mendoza c. Eur J Clin Microbiol Infect Dis. 1999 Apr;18(4):256-9. doi: 10.1007/s100960050273. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10385013

5

Association between submaximal suppression of HIV replication and use of drug combinations without protease inhibitors.

de Mendoza C, Soriano V, González-Lahoz J. de Mendoza C, et al. Eur J Clin Microbiol Infect Dis. 1999 Aug;18(8):604-5. doi: 10.1007/s100960050358. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10517203 No abstract available.

6

Hydroxyurea plus didanosine as maintenance therapy after 1 year on highly active antiretroviral therapy.

Barreiro P, de Mendoza C, Soriano V, González-Lahoz J. Barreiro P, et al. Among authors: de mendoza c. AIDS. 2000 Jan 28;14(2):207-8. doi: 10.1097/00002030-200001280-00020. AIDS. 2000. PMID: 10708295 No abstract available.

7

Different outcomes in patients achieving complete or partial viral load suppression on antiretroviral therapy.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodés B, Casas E, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 1999 Nov-Dec;2(6):344-9. J Hum Virol. 1999. PMID: 10774551

8

Emergence of zidovudine resistance in HIV-infected patients receiving stavudine.

de Mendoza C, Soriano V, Briones C, Gallego O, Barreiro P, Alvarez A, González-Lahoz J. de Mendoza C, et al. J Acquir Immune Defic Syndr. 2000 Mar 1;23(3):279-81. doi: 10.1097/00126334-200003010-00013. J Acquir Immune Defic Syndr. 2000. PMID: 10839665 No abstract available.

9

Efficacy and safety of didanosine and lamivudine both once daily plus indinavir in human immunodeficiency virus-infected patients.

de Mendoza C, Soriano V, Pérez-Olmeda M, Rodríguez-Rosado R, González-Lahoz J. de Mendoza C, et al. J Hum Virol. 2000 Nov-Dec;3(6):335-40. J Hum Virol. 2000. PMID: 11100914 Clinical Trial.

10

Monthly cyclic therapy in heavily pretreated HIV-infected patients.

Soriano V, Barreiro P, de Mendoza C, Dona C, González-Lahoz J. Soriano V, et al. Among authors: de mendoza c. AIDS Patient Care STDS. 2001 Apr;15(4):177-9. doi: 10.1089/10872910151133666. AIDS Patient Care STDS. 2001. PMID: 11359658 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters